Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX)

CUSIP: 14161W105

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / Common Stock, par value $0.0001
Shares outstanding
53,041,500
Total 13F shares
30,794,820
Share change
-3,193,681
Total reported value
$98,563,618
Put/Call ratio
63%
Price per share
$3.20
Number of holders
109
Value change
-$20,795,943
Number of buys
49
Number of sells
61

Quarterly Holders Quick Answers

What is CUSIP 14161W105?
CUSIP 14161W105 identifies CDLX - Cardlytics, Inc. - Common Stock, par value $0.0001 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) as of Q3 2024

As of 30 Sep 2024, Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) was held by 109 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 30,794,820 shares. The largest 10 holders included CAS Investment Partners, LLC, BlackRock, Inc., VANGUARD GROUP INC, 683 Capital Management, LLC, KPS Global Asset Management UK Ltd, WORLDLY PARTNERS MANAGEMENT, LLC, BRIGHTLIGHT CAPITAL MANAGEMENT LP, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, and MARSHALL WACE, LLP. This page lists 109 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.